Neurotoxic Mode of Action of Artemisinin

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial Agents and Chemotherapy Vol. 46; no. 3; pp. 821 - 827
Main Authors SCHMUCK, Gabriele, ROEHRDANZ, Elke, HAYNES, Richard K, KAHL, Regine
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.03.2002
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
AbstractList We recently described a screening system designed to detect neurotoxicity of artemisinin derivatives based on primary neuronal brain stem cell cultures (G. Schmuck and R. K. Haynes, Neurotoxicity Res. 2:37-49, 2000). Here, we probe possible mechanisms of this brain stem-specific neurodegeneration, in which artemisinin-sensitive neuronal brain stem cell cultures are compared with nonsensitive cultures (cortical neurons, astrocytes). Effects on the cytoskeleton of brain stem cell cultures, but not that of cortical cell cultures, were visible after 7 days. However, after a recovery period of 7 days, this effect also became visible in cortical cells and more severe in brain stem cell cultures. Neurodegeneration appears to be induced by effects on intracellular targets such as the cytoskeleton, modulation of the energy status by mitochondrial or metabolic defects, oxidative stress or excitotoxic events. Artemisinin reduces intracellular ATP levels and the potential of the inner mitochondrial membrane below the cytotoxic concentration range in all three cell cultures, with these effects being most dominant in the brain stem cultures. Surprisingly, there were substantial effects on cortical neurons after 7 days and on astrocytes after 1 day. Artemisinin additionally induces oxidative stress, as observed as an increase of reactive oxygen species and of lipid peroxidation in both neuronal cell types. Interestingly, an induction of expression of AOE was only seen in astrocytes. Here, manganese superoxide dismutase (MnSOD) expression was increased more than 3-fold and catalase expression was increased more than 1.5-fold. In brain stem neurons, MnSOD expression was dose dependently decreased. Copper-zinc superoxide dismutase and glutathione peroxidase, two other antioxidant enzymes that were investigated, did not show any changes in their mRNA expression in all three cell types after exposure to artemisinin.
ABSTRACT We recently described a screening system designed to detect neurotoxicity of artemisinin derivatives based on primary neuronal brain stem cell cultures (G. Schmuck and R. K. Haynes, Neurotoxicity Res. 2:37-49, 2000). Here, we probe possible mechanisms of this brain stem-specific neurodegeneration, in which artemisinin-sensitive neuronal brain stem cell cultures are compared with nonsensitive cultures (cortical neurons, astrocytes). Effects on the cytoskeleton of brain stem cell cultures, but not that of cortical cell cultures, were visible after 7 days. However, after a recovery period of 7 days, this effect also became visible in cortical cells and more severe in brain stem cell cultures. Neurodegeneration appears to be induced by effects on intracellular targets such as the cytoskeleton, modulation of the energy status by mitochondrial or metabolic defects, oxidative stress or excitotoxic events. Artemisinin reduces intracellular ATP levels and the potential of the inner mitochondrial membrane below the cytotoxic concentration range in all three cell cultures, with these effects being most dominant in the brain stem cultures. Surprisingly, there were substantial effects on cortical neurons after 7 days and on astrocytes after 1 day. Artemisinin additionally induces oxidative stress, as observed as an increase of reactive oxygen species and of lipid peroxidation in both neuronal cell types. Interestingly, an induction of expression of AOE was only seen in astrocytes. Here, manganese superoxide dismutase (MnSOD) expression was increased more than 3-fold and catalase expression was increased more than 1.5-fold. In brain stem neurons, MnSOD expression was dose dependently decreased. Copper-zinc superoxide dismutase and glutathione peroxidase, two other antioxidant enzymes that were investigated, did not show any changes in their mRNA expression in all three cell types after exposure to artemisinin.
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
Author Regine Kahl
Elke Roehrdanz
Richard K. Haynes
Gabriele Schmuck
AuthorAffiliation Pharma Research Center, Bayer AG, D-42096, Wuppertal, 1 Department of Toxicology, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany, 3 Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong 2
AuthorAffiliation_xml – name: Pharma Research Center, Bayer AG, D-42096, Wuppertal, 1 Department of Toxicology, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany, 3 Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong 2
Author_xml – sequence: 1
  givenname: Gabriele
  surname: SCHMUCK
  fullname: SCHMUCK, Gabriele
  organization: Pharma Research Center, Bayer AG, 42096, Wuppertal, South Africa
– sequence: 2
  givenname: Elke
  surname: ROEHRDANZ
  fullname: ROEHRDANZ, Elke
  organization: Pharma Research Center, Bayer AG, 42096, Wuppertal, South Africa
– sequence: 3
  givenname: Richard K
  surname: HAYNES
  fullname: HAYNES, Richard K
  organization: Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay Kowloon, Hong-Kong
– sequence: 4
  givenname: Regine
  surname: KAHL
  fullname: KAHL, Regine
  organization: Department of Toxicology, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13499427$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/11850267$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtPGzEUhS1EBYH2J4CyadXNDH4_FiyiqC-Jlk27tu54PMRoYoM908e_r9NE0K66sOwrf-ce3-MzdBxT9AhdENwSQvXVarVuuWxZqylpNFUtxZgeoQXBRjdSGHmMFhhL2XCN-Sk6K-Ue11oYfIJOCdECU6kW6O0XP-c0pZ_BLT-n3i_TsFy5KaT455Qnvw0lxBBfohcDjMW_Ouzn6Nv7d1_XH5ub2w-f1qubBoRWUyMABCWckEGxznS17CV1ous7pzF4ZgboYNCqZ4YwwNz5QRrRaSU98Z3H7Bxd7_s-zN3W987HKcNoH3LYQv5lEwT7700MG3uXvltCFdeq6t8c9Dk9zr5Mtg7g_DhC9GkulmgqhSY7UOxBl1Mp2Q9PHgTbXcS2Rmy5tMzWiOtSdhdx1dG9DsqW2vs051jz-K_o8u-pnq0OH1GB1wcAioNxyBBdKM8c48ZwuuOWe24T7jY_Qva2PsMCuCdT9huqJKCf
CODEN AACHAX
CitedBy_id crossref_primary_10_1074_jbc_M610375200
crossref_primary_10_3389_fncel_2018_00108
crossref_primary_10_1128_AAC_00373_07
crossref_primary_10_1016_j_toxlet_2006_09_002
crossref_primary_10_1016_j_neuron_2019_01_001
crossref_primary_10_1016_j_semcancer_2017_01_006
crossref_primary_10_1177_0960327114532385
crossref_primary_10_1016_j_actatropica_2009_08_002
crossref_primary_10_1016_j_ejmech_2018_12_007
crossref_primary_10_1016_j_genhosppsych_2008_10_004
crossref_primary_10_1016_j_bcp_2011_06_002
crossref_primary_10_1002_cmdc_201600011
crossref_primary_10_1158_0008_5472_CAN_07_2970
crossref_primary_10_1155_2012_247597
crossref_primary_10_1021_acschemneuro_1c00120
crossref_primary_10_1002_cmdc_200600240
crossref_primary_10_1002_ptr_5958
crossref_primary_10_1002_ana_25028
crossref_primary_10_1002_cmdc_200900342
crossref_primary_10_1016_j_mcn_2021_103624
crossref_primary_10_1021_acsabm_8b00358
crossref_primary_10_1002_cmdc_201700600
crossref_primary_10_1016_S0020_7519_02_00194_7
crossref_primary_10_3109_15376516_2011_552534
crossref_primary_10_1016_j_cbi_2003_12_005
crossref_primary_10_3923_ajb_2011_373_383
crossref_primary_10_1016_j_ijpddr_2017_05_002
crossref_primary_10_1128_AAC_01553_13
crossref_primary_10_1016_j_ejmech_2016_07_027
crossref_primary_10_1021_cr500543f
crossref_primary_10_1016_j_ijpara_2006_07_011
crossref_primary_10_1016_j_toxlet_2006_06_001
crossref_primary_10_1002_ange_200503071
crossref_primary_10_3109_10408441003610571
crossref_primary_10_1016_S0161_813X_02_00096_7
crossref_primary_10_14336_AD_2019_0813
crossref_primary_10_1586_eri_09_53
crossref_primary_10_1002_cmdc_201200383
crossref_primary_10_1080_02772240802445522
crossref_primary_10_1002_ana_20620
crossref_primary_10_1128_AAC_00375_11
crossref_primary_10_1186_1475_2875_7_179
crossref_primary_10_1016_j_tet_2018_04_027
crossref_primary_10_1021_acs_biomac_7b00852
crossref_primary_10_1016_j_ijbiomac_2021_01_072
crossref_primary_10_1016_j_molmed_2006_03_005
crossref_primary_10_1016_j_trstmh_2006_09_001
crossref_primary_10_1002_cbic_200400366
crossref_primary_10_5897_AJPP2017_4777
crossref_primary_10_1002_cmdc_201000225
crossref_primary_10_1016_j_trstmh_2006_10_003
crossref_primary_10_1002_ardp_201600335
crossref_primary_10_1155_2013_965046
crossref_primary_10_1002_anie_200503071
crossref_primary_10_1016_j_medmal_2019_02_005
crossref_primary_10_1016_j_pt_2006_05_011
crossref_primary_10_5530_ax_2011_1_7
crossref_primary_10_3390_molecules23071713
crossref_primary_10_3390_pharmaceutics13122066
crossref_primary_10_1016_j_etap_2016_03_018
crossref_primary_10_3390_ijms20112680
crossref_primary_10_1517_13543776_13_11_1763
crossref_primary_10_1002_anie_200352343
crossref_primary_10_1002_bdrb_20282
crossref_primary_10_1016_j_tox_2007_08_084
crossref_primary_10_1016_j_vetpar_2011_12_020
crossref_primary_10_1016_j_phrs_2018_09_002
crossref_primary_10_1186_1471_2202_10_88
crossref_primary_10_2174_1568026619666190412104042
crossref_primary_10_1007_s11250_010_9771_3
crossref_primary_10_1073_pnas_2008695117
crossref_primary_10_1086_502658
crossref_primary_10_1186_s12936_015_0682_7
crossref_primary_10_1007_s40263_019_00649_9
crossref_primary_10_1186_1475_2875_9_227
crossref_primary_10_1016_j_ejphar_2022_175467
crossref_primary_10_1002_ange_200352343
crossref_primary_10_1016_j_etap_2005_07_006
crossref_primary_10_1016_j_tips_2008_07_004
crossref_primary_10_1016_S0140_6736_06_67958_0
crossref_primary_10_3390_molecules21101331
Cites_doi 10.7164/antibiotics.52.880
10.1056/NEJM199607113350202
10.1006/taap.1997.8344
10.1016/0024-3205(95)00055-B
10.1016/S0021-9258(17)43645-3
10.2165/00002018-199512060-00003
10.4269/ajtmh.1997.56.390
10.1007/s004290050326
10.4269/ajtmh.1999.60.547
10.1177/074823379601200507
10.1016/S0361-9230(97)00339-0
10.1073/pnas.83.2.313
10.1080/00034983.1996.11813022
10.1080/00034983.1995.11812975
10.1126/science.3887571
10.1016/0014-5793(92)80198-P
10.1093/nar/15.16.6746
10.1111/j.1440-1681.1995.tb02015.x
10.1007/BF03033326
10.1056/NEJM199607113350201
10.1006/taap.1995.1163
10.1093/nar/15.23.10070
10.1016/S0021-9258(18)54242-3
10.1016/S0140-6736(84)92457-7
10.1016/S0014-5793(00)01592-1
ContentType Journal Article
Copyright 2002 INIST-CNRS
Copyright © 2002 American Society for Microbiology
Copyright © 2002, American Society for Microbiology 2002
Copyright_xml – notice: 2002 INIST-CNRS
– notice: Copyright © 2002 American Society for Microbiology
– notice: Copyright © 2002, American Society for Microbiology 2002
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
7U7
C1K
5PM
DOI 10.1128/AAC.46.3.821-827.2002
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Neurosciences Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Toxicology Abstracts
Neurosciences Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE
CrossRef



Toxicology Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
Biology
EISSN 1098-6596
EndPage 827
ExternalDocumentID 10_1128_AAC_46_3_821_827_2002
0608
11850267
13499427
aac_46_3_821
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
.55
.GJ
08R
0R~
23M
2WC
39C
3O-
4.4
53G
5GY
5RE
5VS
6J9
8W4
AAPBV
ABFLS
ACGFO
ADBBV
ADGIM
AENEX
AFMIJ
AGNAY
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HH5
HYE
HZ~
H~9
IQODW
J5H
K-O
KQ8
L7B
LSO
MVM
NEJ
O9-
OK1
P2P
RHF
RHI
RNS
RPM
RSF
TR2
UHB
VH1
W2D
W8F
WH7
WHG
WOQ
X7M
X7N
XOL
Y6R
ZA5
ZGI
ZXP
~A~
CGR
CUY
CVF
ECM
EIF
NPM
-
0R
55
A
ADACO
ADBIT
BXI
GJ
HZ
AAYXX
CITATION
7TK
7U7
C1K
5PM
ID FETCH-LOGICAL-a587t-5aa521411f73b9b5aad62c5bdbc80ae39fabaf87d3913a04cef695b876e1ebe03
IEDL.DBID RPM
ISSN 0066-4804
IngestDate Tue Sep 17 21:04:08 EDT 2024
Sat Aug 17 02:39:51 EDT 2024
Thu Sep 12 16:51:24 EDT 2024
Tue Dec 28 13:59:20 EST 2021
Sun Oct 13 09:37:39 EDT 2024
Thu Nov 24 18:22:06 EST 2022
Wed May 18 15:27:01 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Glutathione peroxidase
Antimalarial
Oxidative stress
Enzyme
Toxicity
Artemisinin
Lipids
Superoxide dismutase
Gene expression
Cerebral disorder
Neuron
Peroxidases
Parasiticid
Central nervous system disease
Cytoskeleton
Oxidoreductases
Mechanism of action
Peroxidation
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a587t-5aa521411f73b9b5aad62c5bdbc80ae39fabaf87d3913a04cef695b876e1ebe03
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Present address: Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), 53113 Bonn, Germany.
Corresponding author. Mailing address: BAYER AG, Pharma Research Centre, Aprather Weg, D-42096 Wuppertal, Germany. Phone: 0049 202 368830. Fax: 0049 202 364137. E-mail: GABRIELE.SCHMUCK.GS@bayer-ag.de.
OpenAccessLink https://europepmc.org/articles/pmc127487?pdf=render
PMID 11850267
PQID 18265817
PQPubID 23462
PageCount 7
ParticipantIDs proquest_miscellaneous_18265817
pubmed_primary_11850267
pascalfrancis_primary_13499427
pubmedcentral_primary_oai_pubmedcentral_nih_gov_127487
crossref_primary_10_1128_AAC_46_3_821_827_2002
asm2_journals_10_1128_AAC_46_3_821_827_2002
highwire_asm_aac_46_3_821
PublicationCentury 2000
PublicationDate 2002-03-01
PublicationDateYYYYMMDD 2002-03-01
PublicationDate_xml – month: 03
  year: 2002
  text: 2002-03-01
  day: 01
PublicationDecade 2000
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Antimicrobial Agents and Chemotherapy
PublicationTitleAbbrev AAC
PublicationTitleAlternate Antimicrob Agents Chemother
PublicationYear 2002
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_27_2
(e_1_3_2_34_2) 1998; 24
(e_1_3_2_14_2) 1998; 45
(e_1_3_2_17_2) 1987; 15
(e_1_3_2_2_2) 1995; 22
e_1_3_2_40_2
(e_1_3_2_44_2) 1995; 36
(e_1_3_2_6_2) 1998; 58
(e_1_3_2_36_2) 1996; 12
e_1_3_2_23_2
(e_1_3_2_45_2) 1996; 335
(e_1_3_2_32_2) 1995; 12
(e_1_3_2_9_2) 1984; 259
(e_1_3_2_5_2) 1994; 88
(e_1_3_2_24_2) 1992
(e_1_3_2_42_2) 1999; 52
(e_1_3_2_31_2) 2000; 201
(e_1_3_2_37_2) 2000; 13
(e_1_3_2_22_2) 2000; 474
(e_1_3_2_19_2) 1992; 301
(e_1_3_2_11_2) 1999; 158
(e_1_3_2_21_2) 1994; 15
(e_1_3_2_18_2) 1987; 15
(e_1_3_2_41_2) 1998; 19
(e_1_3_2_8_2) 1997
e_1_3_2_38_2
(e_1_3_2_15_2) 1995; 89
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_39_2
(e_1_3_2_4_2) 1995; 56
(e_1_3_2_35_2) 2001; 3
(e_1_3_2_13_2) 1986; 83
(e_1_3_2_12_2) 1998; 19
(e_1_3_2_43_2) 1997; 51
(e_1_3_2_10_2) 1995; 134
e_1_3_2_33_2
(e_1_3_2_20_2) 1998; 148
(e_1_3_2_30_2) 1997; 56
(e_1_3_2_25_2) 1999; 30
(e_1_3_2_26_2) 1996; 90
(e_1_3_2_28_2) 1998; 58
(e_1_3_2_3_2) 1996; 67
(e_1_3_2_29_2) 2001; 17
References_xml – volume: 3
  start-page: 150
  year: 2001
  ident: e_1_3_2_35_2
  publication-title: Arch. Toxicol.
– volume: 52
  start-page: 880
  year: 1999
  ident: e_1_3_2_42_2
  publication-title: J. Antibiot.
  doi: 10.7164/antibiotics.52.880
– ident: e_1_3_2_16_2
  doi: 10.1056/NEJM199607113350202
– volume: 148
  start-page: 288
  year: 1998
  ident: e_1_3_2_20_2
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1006/taap.1997.8344
– volume: 56
  start-page: 1151
  year: 1995
  ident: e_1_3_2_4_2
  publication-title: Life Sci.
  doi: 10.1016/0024-3205(95)00055-B
– volume: 259
  start-page: 224
  year: 1984
  ident: e_1_3_2_9_2
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(17)43645-3
– volume: 13
  start-page: 37
  year: 2000
  ident: e_1_3_2_37_2
  publication-title: In vitro Mol. Toxicol.
– volume: 12
  start-page: 370
  year: 1995
  ident: e_1_3_2_32_2
  publication-title: Drug Safety
  doi: 10.2165/00002018-199512060-00003
– volume: 56
  start-page: 390
  year: 1997
  ident: e_1_3_2_30_2
  publication-title: Am. J. Trop. Med. Hyg.
  doi: 10.4269/ajtmh.1997.56.390
– volume: 201
  start-page: 383
  year: 2000
  ident: e_1_3_2_31_2
  publication-title: Anat. Embryol.
  doi: 10.1007/s004290050326
– ident: e_1_3_2_33_2
  doi: 10.4269/ajtmh.1999.60.547
– volume: 12
  start-page: 683
  year: 1996
  ident: e_1_3_2_36_2
  publication-title: Toxicol. Ind. Health
  doi: 10.1177/074823379601200507
– volume: 58
  start-page: 28
  year: 1998
  ident: e_1_3_2_28_2
  publication-title: Med. Trop.
– volume: 88
  start-page: 33
  year: 1994
  ident: e_1_3_2_5_2
  publication-title: Trans. R. Soc. Trop. Med. Hyg.
– volume: 45
  start-page: 199
  year: 1998
  ident: e_1_3_2_14_2
  publication-title: Brain Res. Bull.
  doi: 10.1016/S0361-9230(97)00339-0
– volume: 83
  start-page: 313
  year: 1986
  ident: e_1_3_2_13_2
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.83.2.313
– volume: 24
  start-page: 27
  year: 1998
  ident: e_1_3_2_34_2
  publication-title: Med.
– volume: 58
  start-page: 22S
  year: 1998
  ident: e_1_3_2_6_2
  publication-title: Med. Trop.
– start-page: 111
  year: 1992
  ident: e_1_3_2_24_2
  publication-title: Selective neurotoxicity
– volume: 90
  start-page: 21
  year: 1996
  ident: e_1_3_2_26_2
  publication-title: Ann. Trop. Med. Parasitol.
  doi: 10.1080/00034983.1996.11813022
– volume: 89
  start-page: 447
  year: 1995
  ident: e_1_3_2_15_2
  publication-title: Ann. Trop. Med. Parasitol.
  doi: 10.1080/00034983.1995.11812975
– ident: e_1_3_2_23_2
  doi: 10.1126/science.3887571
– volume: 36
  start-page: 1271
  year: 1995
  ident: e_1_3_2_44_2
  publication-title: Investig. Ophthalmol. Vis. Sci.
– volume: 67
  start-page: 2484
  year: 1996
  ident: e_1_3_2_3_2
  publication-title: J. Biochem.
– volume: 301
  start-page: 5
  year: 1992
  ident: e_1_3_2_19_2
  publication-title: FEBS Lett.
  doi: 10.1016/0014-5793(92)80198-P
– volume: 15
  start-page: 6746
  year: 1987
  ident: e_1_3_2_18_2
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/15.16.6746
– ident: e_1_3_2_39_2
– volume: 22
  start-page: 358
  year: 1995
  ident: e_1_3_2_2_2
  publication-title: Clin. Exp. Pharmacol. Physiol.
  doi: 10.1111/j.1440-1681.1995.tb02015.x
– start-page: 5
  year: 1997
  ident: e_1_3_2_8_2
  publication-title: The role of oxidative stress in neuronal death
– volume: 158
  start-page: 2
  year: 1999
  ident: e_1_3_2_11_2
  publication-title: Toxicol. Appl. Pharmacol.
– volume: 15
  start-page: 887
  year: 1994
  ident: e_1_3_2_21_2
  publication-title: Neurotoxicology
– ident: e_1_3_2_38_2
  doi: 10.1007/BF03033326
– volume: 30
  start-page: 636
  year: 1999
  ident: e_1_3_2_25_2
  publication-title: Southeast Asian J. Trop. Med. Public Health
– ident: e_1_3_2_27_2
– volume: 335
  start-page: 69
  year: 1996
  ident: e_1_3_2_45_2
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199607113350201
– volume: 17
  start-page: 123
  year: 2001
  ident: e_1_3_2_29_2
  publication-title: Trends Parasitol.
– volume: 19
  start-page: 393
  year: 1998
  ident: e_1_3_2_12_2
  publication-title: Neurotoxicology
– volume: 134
  start-page: 1
  year: 1995
  ident: e_1_3_2_10_2
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1006/taap.1995.1163
– volume: 15
  start-page: 10070
  year: 1987
  ident: e_1_3_2_17_2
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/15.23.10070
– ident: e_1_3_2_40_2
  doi: 10.1016/S0021-9258(18)54242-3
– volume: 19
  start-page: 557
  year: 1998
  ident: e_1_3_2_41_2
  publication-title: Neurotoxicology
– volume: 51
  start-page: 451
  year: 1997
  ident: e_1_3_2_43_2
  publication-title: J. Antibiot.
– ident: e_1_3_2_7_2
  doi: 10.1016/S0140-6736(84)92457-7
– volume: 474
  start-page: 238
  year: 2000
  ident: e_1_3_2_22_2
  publication-title: FEBS Lett.
  doi: 10.1016/S0014-5793(00)01592-1
SSID ssj0006590
Score 2.0919383
Snippet Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
We recently described a screening system designed to detect neurotoxicity of artemisinin derivatives based on primary neuronal brain stem cell cultures (G....
ABSTRACT We recently described a screening system designed to detect neurotoxicity of artemisinin derivatives based on primary neuronal brain stem cell...
SourceID pubmedcentral
proquest
crossref
asm2
pubmed
pascalfrancis
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 821
SubjectTerms Adenosine Triphosphate - metabolism
Animals
Antimalarials
Antimalarials - toxicity
artemisinin
Artemisinins
Artemsisia Annua
Biological and medical sciences
Cell Survival
Cells, Cultured
Cytoskeleton - drug effects
Cytoskeleton - metabolism
Drug toxicity and drugs side effects treatment
Energy Metabolism - drug effects
Enzyme-Linked Immunosorbent Assay
Lipid Peroxidation - drug effects
Mechanisms of Action: Physiological Effects
Medical sciences
Membrane Potentials
Mitochondria - drug effects
Mitochondria - physiology
Neurofilament Proteins - metabolism
Neurons - drug effects
Neurons - metabolism
Neurotoxicity Syndromes
Neurotoxicity Syndromes - pathology
Neurotoxins
Neurotoxins - toxicity
Oxidative Stress - drug effects
Pharmacology. Drug treatments
Rats
Reactive Oxygen Species - metabolism
RNA - biosynthesis
RNA - genetics
Sesquiterpenes
Sesquiterpenes - toxicity
Toxicity: nervous system and muscle
Title Neurotoxic Mode of Action of Artemisinin
URI http://aac.asm.org/content/46/3/821.abstract
https://www.ncbi.nlm.nih.gov/pubmed/11850267
https://journals.asm.org/doi/10.1128/AAC.46.3.821-827.2002
https://search.proquest.com/docview/18265817
https://pubmed.ncbi.nlm.nih.gov/PMC127487
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_WwsZexpZ9eVszP4wyWO3Y1qcfQ2jpNjLy0ELfhGTLNLA4ZU5h-e93kuWmGYNBHww2lixbP0l3Z_3uDuCTlszUEmda3ZgyobqsEm1yPJOVFtxym3tuzvwHP7-k367YVXAK6wKtsq3MMm1_rtJ2ee25lTerajLwxCaL-SxHU0qKyQEcCEIGCz2svpz1_1VQlGKDGQ1eO7gMT6bTWUp5SlJZ5IkshCcouKihKLNcIiZclXW3KvYl1BA12JEmdYf91vQJL_6lkf5NrLwnqc6ew7OgYsbT_lNewCPbjuBxn3RyO4In87CdPoLjRR-4ensSX-z8sLqT-Dhe7EJab1_CZx_DY7P-vaxilz0tXjfx1HtE-DPH1112LtXEK7g8O72YnSchx0KimRSbhGmNApzmeSOIKQ1e1ryoED9TyUxbUjba6EaKmpQ50RmtbMNLZnANtTnin5HXcNiuW_sWYlNkRnDDmK01paLRzJYiswZ1UlGjVhbBF9e9KkySTnn7o5AKcVGUK6IQFzyES41ZRJAOKKibPvDG_ypEA1YK21FaV3eFIhjvgbd7IkGLjxYigo8Dmgo7zG2a6Naub_El0f5iMscSb3psd3XDsImA76F-V8BF7t6_gwPaR_DuB_C7h1Z8D099UhpPhfsAh5tft_YIdaONGaNV8PX72E-JPys_Ceo
link.rule.ids 230,315,733,786,790,891,27955,27956,53825,53827
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD6CIS4vXMqAcNnygCYkljQX3_JYVUwF1qkPrbQ3y3YcUUHTiaQS5ddz4iQrnZAQPERyFDsX-7N9Tvz5OwBvlaA6F9jT8kJnAVGZCZSOMSWM4swyGztuzvSCTRbk0yW97DaFVR2tsjR6GZbfVmG5_OK4lVcrM-x5YsPZdByjKyX48Dbcwe6a0N5H78ZfRts_KziZ4iMj0u3bwYF4OBqNQ8LCNBRJHIiEO4pCoxuKs1YTignHZVWtkv05qtcNbmiTqsKaK9qQF3-ySW9SK3-bq84ewaL_ypai8jXc1Do0P28IQP5rNTyGh53x6o_aq0_gli0HcLcNZ7kdwL1pt1A_gJNZK4m9PfXnux1e1al_4s92Ytnbp_DOqYPU6x9L4zdx2fx14Y_cXguXapjAy6oJYnEIi7MP8_Ek6KI3BIoKXgdUKTQNSBwXPNWZxtOcJQaRoY2IlE2zQmlVCJ6nWZyqiBhbsIxqHJ1tjMiK0mdwUK5L-wJ8nUSaM02pzRUhvFDUZjyyGq1dnqO958H7ptlk1_0q6TybREhsb0mYTCW2Nx68CbqZeBD2rSuvWkmPvxXwegxIfI5Uylxn8uBoDxS7O6boS5KEe3Dco0RihTXLMaq06w2-JHp2VMSY43mLmV3ZDo4esD00XWdoNMH3ryBGnDZ4i4mX_1vwGO5P5tNzef7x4vMreOBC3zjC3Ws4qL9v7Bu0wGp95DrcLyYkKrM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD4aQ0y8cCkMwmXLA5qQWO7xJY9VoRqXTn3YpPFk2Y4jKmha0VSi_HqOnWSlExLSHiIlih0n9mf7nPjzdwDeSE5UybGnlZUqglwWOpAqwTOuJaOGmsRxcybn9Owy_3RFrvaA93thHGlfq1lY_5iH9eyb41Yu5zrqeWLRdDJK0JXiLFqWVXQH7mKXTVnvp3djMCXt3xWcULHYOO_27uBgHA2HozCnYRbyNAkwp6MpWO1QnLlsOCYcm-Vqnu7OU712sKVOyhXWXtWGvfiXXXqTXvnXfDV-CF_7L21pKt_DdaNC_fuGCORtquIRPOiMWH_YpngMe6YewL02rOVmAAeTbsF-ACfTVhp7c-pfbHd6rU79E3-6Fc3ePIG3TiWkWfyaad_GZ_MXlT90ey7cmWUEz1Y2mMVTuBx_uBidBV0Uh0ASzpqASIkmQp4kFctUofCypKlGhCjNY2myopJKVpyVWZFkMs61qWhBFI7SJkGExdkh7NeL2jwHX6WxYlQRYkqZ56ySxBQsNgqtXlai3efBO9t0ouuGK-E8nJQLbHORU5EJbHM8mA2-mXoQ9i0slq20x_8yeD0OBJYjpNTXiTw42gHG9okZ-pR5yjw47pEisMLssoyszWKNL4keHuEJpnjW4mabt4OkB3QHUdcJrDb47h3EidMIb3Hx4rYZj-Fg-n4svnw8__wS7rsIOI539wr2m59r8xoNsUYduT73B56oLTM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neurotoxic+Mode+of+Action+of+Artemisinin&rft.jtitle=Antimicrobial+agents+and+chemotherapy&rft.au=Schmuck%2C+G&rft.au=Roehrdanz%2C+E&rft.au=Haynes%2C+R+K&rft.au=Kahl%2C+R&rft.date=2002-03-01&rft.issn=0066-4804&rft.volume=46&rft.issue=3&rft.spage=821&rft.epage=827&rft_id=info:doi/10.1128%2FAAC.46.3.821-827.2002&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0066-4804&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0066-4804&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0066-4804&client=summon